Eliminating lymphatic filariasis: A view from the field

Annals of the New York Academy of Sciences

Volumn 1136, Issue , 2008, Pages 53-63

  Streit, Thomas ^a   Lafontant, Jack Guy ^a,b  

^a UNIVERSITY OF NOTRE DAME   (United States)

^b Haiti State University Hospital   (Haïti)

Author keywords

Disease elimination; Drug donation; Elephantiasis; Haiti; Hydrocele; Lymphatic filariasis; Lymphedema; Mass chemotherapy; Poverty; Rapid diagnostics

Indexed keywords

CAUSAL ATTRIBUTION; DISABILITY; DISEASE TRANSMISSION; FILARIASIS; HUMAN; INFECTION CONTROL; INFECTION RISK; INTERNATIONAL COOPERATION; LYMPHATIC FILARIASIS; POVERTY; PREVALENCE; PUBLIC HEALTH PROBLEM; REVIEW; SOCIAL WELFARE; SOCIOECONOMICS; TREATMENT INDICATION;

EID: 45549102728     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1425.036     Document Type: Review

References (71)

1. Michael, E., D.A. Bundy & B.T. Grenfell. 1996. Re-assessing the global prevalence and distribution of lymphatic filariasis. Parasitology 112:409 428.
2. Ottesen, E.A. 2006. Lymphatic filariasis: treatment, control and elimination. Adv. Parasitol. 61:395 441.
3. Addiss, D.G. & G. Dreyer. 2000. Treatment of lymphatic filariasis. In Lymphatic Filariasis. T.B. Nutman, Ed.:151 199. Imperial College Press. London.
4. World Health Organization. 2001. Lymphatic filariasis. Wkly. Epidemiol. Rec. 76:149 151.
5. International Task Force for Disease Eradication. 1993. Recommendations of the International Task Force for Disease Eradication. MMWR Recomm. Rep. 42:1 38.
6. World Health Assembly. 1997. Resolution WHA50.29. Elimination of lymphatic filariasis as a public health problem. In Fiftieth World Health Assembly 5-14 May 1997. Resolutions and Decisions (WHA50/1997/REC/1):27 28. World Health Organization. Geneva.
7. Ottesen, E.A., B.O.L. Duke, M. Karam & K. Behbehani. 1997. Strategies and tools for the control/elimination of lymphatic filariasis. Bull. World Health Organ. 75:491 503.
8. Jappe, U. 2002. Unusual skin infections in military personnel. Clin. Dermatol. 20:425 434.
9. Leggat, P.A. & W. Melrose. 2005. Lymphatic filariasis: disease outbreaks in military deployments from World War II. Mil. Med. 170:585 589.
10. Lipner, M., M.A. Law, E. Barnett, et al. 2007. Filariasis in travelers presenting to the GeoSentinel Surveillance Network. PLoS Negl. Trop. Dis. 1:e88.
11. Boyd, H.A., L.A. Waller, W.D. Flanders, et al. 2004. Community- and individual-level determinants of Wuchereria bancrofti infection in Leogane Commune, Haiti. Am. J. Trop. Med. Hyg. 70:266 272.
12. Grove, D.I., F.S. Valeza & B.D. Cabrera. 1978. Bancroftian filariasis in a Philippine village: clinical, parasitological, immunological and social aspects. Bull. World Health Organ. 56:975 984.
13. Perera, M., M. Whitehead, D. Molyneux, et al. 2002. Neglected patients with a neglected disease? A qualitative study of lymphatic filariasis. PLoS Negl. Trop. Dis. 1:e128.
14. Galvez Tan, J.Z. 2003. The elimination of lymphatic filariasis: a strategy for poverty alleviation and sustainable development - perspectives from the Philippines. Filaria J. 2:12.
15. Molyneux, D.H. & N. Zagaria. 2002. Lymphatic filariasis elimination: progress in global programme development. Ann. Trop. Med. Parasitol. 96:S15 S40.
16. Gwatkin, D.R., M. Guillot & P. Heuveline. 1999. The burden of disease among the global poor. Lancet 354:586 589.
17. Heyman, D.L. 2004. Control of Communicable Diseases Manual, 18th ed. 700 pp. American Public Health Association. Washington, DC.
18. Smith, R.R. 2002. Sanitation: Controlling Problems at Source. WHO document; WHO/WSH/WWD/TA.8.
19. Zagaria, N. & L. Savioli. 2002. Elimination of lymphatic filariasis: a public-health challenge. Ann. Trop. Med. Parasitol. 96 (Suppl 2 S3 S13.
20. Evans, D.B., H. Gelband & C. Vlassoff. 1993. Social and economic factors and the control of lymphatic filariasis: a review. Acta Tropica. 53:1 26.
21. Addiss, D.G. & M.A. Brady. 2007. Morbidity management in the Global Programme to Eliminate Lymphatic Filariasis: a review of the scientific literature. Filaria J. 6:e2.
22. Raccurt, C. 2004. Malaria in Haiti today. Sante 14:201 204.
23. Michael, E. 2000. The population dynamics and epidemiology of lymphatic filariasis. In Lymphatic Filariasis. T.B. Nutman, Ed.:41 81. Imperial College Press. London.
24. Chernin, E. 1987. The disappearance of Bancroftian filariasis from Charleston, South Carolina. Am. J. Trop. Med. Hyg. 37:111 114.
25. Sprent, J.F. 1986. Parasitology in Brisbane. Int. J. Parasitol. 16:281 285.
26. Lammie, P.J., W.L. Hitch, E.M. Walker, et al. 1991. Maternal filarial infection as risk factor for infection in children. Lancet 337:1005 1006.
27. Cuenco, K.T., M.E. Halloran, J. Louis-Charles, et al. 2004. A family study of lymphedema of the leg in a lymphatic filariasis-endemic area. Am. J. Trop. Med. Hyg. 70:180 184.
28. Cuenco, K.T., M.E. Halloran & P.J. Lammie. 2004. Assessment of families for excess risk of lymphedema of the leg in a lymphatic filariasis-endemic area. Am. J. Trop. Med. Hyg. 70:185 190.
29. Engles, D. & L. Savioli. 2006. Reconsidering the underestimated burden caused by neglected tropical diseases. Trends Parasitol. 22:363 366.
30. Hotez, P.J., D.H. Molyneux, A. Fenwick, et al. 2006. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Med. 3:e102.
31. Stein, C., T. Kuchenmüller, S. Hendrickx, et al. 2007. Global burden of disease assessments - WHO is responsible? PLoS Negl. Trop. Dis. 1:e161.
32. World Health Organization. 1995. World Health Report. 118 pp. World Health Organization. Geneva.
33. World Health Organization. 2000. World Health Report. 206 pp. World Health Organization. Geneva.
34. Molyneux, D.H. 2006. Control of human parasitic diseases: context and overview. Adv. Parasitol. 61:1 45.
35. World Health Organization. 2004. Lymphatic filariasis: progress of disability prevention activities. Wkly. Epidemiol. Rec. 79:417 424.
36. Dreyer, G., J. Norões & D.G. Addiss. 1997. The silent burden of sexual disability associated with lymphatic filariasis. Acta Tropica. 63:57 60.
37. Krishna Kumari, A., K.T. Harichandrakumar, L.K. Das, et al. 2005. Physical and psychosocial burden due to lymphatic filariasis as perceived by patients and medical experts. Trop. Med. Int. Health 10:567 573.
38. Eberhard, M.L., E.M. Walker, D.G. Addiss & P.J. Lammie. 1996. A survey of knowledge, attitudes, and perceptions (KAPs) of lymphatic filariasis, elephantiasis, and hydrocele among residents in an endemic area in Haiti. Am. J. Trop. Med. Hyg. 43:299 303.
39. Weil, G.J., P.J. Lammie & N. Weiss. 1997. The ICT filariasis test: a rapid-format antigen test for diagnosis of Bancroftian filariasis. Parasitol. Today 13:401 404.
40. Ramaiah, K.D., P.K. Das, E. Michael & H. Guyatt. 2000. The economic burden of lymphatic filariasis in India. Parasitol. Today 16:251 253.
41. World Health Organization. 2006. Global Programme to Eliminate Lymphatic Filariasis: progress report on mass drug administrations in 2005. Wkly. Epidemiol. Rec. 81:221 232.
42. Beau de Rochars, M.V.E., M.D. Milord, Y. St. Jean, et al. 2004. Geographic distribution of lymphatic filariasis in Haiti. Am. J. Trop. Med. Hyg. 71:598 601.
43. Wilson, P.W. 1928. Contribution à l'étude de la malaria et de la microfilaire par l'examen de 11,000 travailleurs et de 2,007 enfants. Bull. Soc. Med. Haiti 7:51 63.
44. Voltaire, H.C. 2003. An Agenda for Action. 123 pp. Ministry of Public Health and the Population. Port-au-Prince, Haiti.
45. Medeiros, Z., J. Gomes, F. Béliz, et al. 1999. Screening of army soldiers for Wuchereria bancrofti infection in the metropolitan Recife region, Brazil: implications for epidemiological surveillance. Trop. Med. Int. Health 4:499 505.
46. Burkot, T. & K. Ichimori. 2002. The PacELF programme: will mass drug administration be enough? Trends Parasitol. 18:109 115.
47. Burkot, T. & M. Bockarie. 2004. Vectors. Am. J. Trop. Med. Hyg. 71 (Suppl 5 24 26.
48. Williams, S.A., S.J. Laney, L.A. Bierwert, et al. 2002. Development and standardization of a rapid, PCR-based method for the detection of Wuchereria bancrofti in mosquitoes, for xenomonitoring the human prevalence of Bancroftian filariasis. Ann. Trop. Med. Parasitol. 96:S4l S46.
49. Dadzie, K.Y., M.G. Basáñz & F. Richards. 2004. Epidemiology, parasite biology, modeling. Am. J. Trop. Med. Hyg. 71 (Suppl 5 22 23.
50. Bradley, M.H. & V. Kumaraswami. 2004. Essential tools - drugs and clinical drug trials. Am. J. Trop. Med. Hyg. 71 (Suppl 5 7 11.
51. Gedhin, E., S. Wang, D. Spiro, et al. 2007. Draft genome of the filarial nematode parasite Brugia malayi. Science 317:1756 1760.
52. Hotez, P.J. 2007. A new voice for the poor. PLoS Negl. Trop. Dis. 1:e77.
53. Hotez, P.J. 2007. Control of neglected tropical diseases. N. Engl. J. Med. 357:1018 1027.
54. Molyneaux, D.H., M. Neira, B. Liese & D. Heymann. 2000. Lymphatic filariasis: setting the scene for elimination. Trans. R. Soc. Trop. Med. Hyg. 94:589 591.
55. Ottesen, E.A. 2000. The Global Programme to Eliminate Lymphatic Filariasis. Trop. Med. Int. Health 5:591 594.
56. Molyneaux, D. 2003. Lymphatic filariasis (elephantiasis) elimination: a public health success and development opportunity. Filaria J. 2:13.
57. Hotez, P.J., J.H.F. Remme, P. Buss, et al. 2004. Combating tropical infectious diseases: report of the Disease Control Priorities in Developing Countries Project. Clin. Infect Dis. 38:871 878.
58. Molyneaux, D.H. 2004. "Neglected" diseases but unrecognised successes - challenges and opportunities for infectious disease control. Lancet 364:380 383.
59. Fenwick, A., D. Molyneux & V. Nantulya. 2005. Achieving the Millennium Development Goals 365:1029 1030.
60. Brady, M.A., P.J. Hooper & E.A. Ottesen. 2006. Projected benefits from integrating NTD programs in sub-Saharan Africa. Trends Parasitol. 22:285 291.
61. Hotez, P.J., D.H. Molyneux, E. Stillwaggon, et al. 2006. Neglected tropical diseases and HIV/AIDS. Lancet 368:1865 1866.
62. Lammie, P.J., A. Fenwick & J. Utzinger. 2006. A blueprint for success: integration of neglected tropical disease control programmes. Trends Parasitol. 22:313 321.
63. Molyneaux, D.H. 2006. Elimination of transmission of lymphatic filariasis in Egypt. Lancet 367:966 968.
64. Brooker, S., A. Willis, R. Pullan, et al. 2007. Epidemiology of Plasmodium-helminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining control. Am. J. Trop. Med. Hyg. 77 (Suppl 6 88 98.
65. Hotez, P. 2007. Measuring neglect. PLoS Negl. Trop. Dis. 1:e118.
66. Hotez, P., S. Raff, A. Fenwick, et al. 2007. Recent progress in integrated neglected tropical disease control. Trends Parasitol. 23:511 514.
67. Lammie, P.J., J.F. Lindo, W.E. Secor, et al. 2007. Eliminating lymphatic filariasis, onchocerciasis, and schistosomiasis from the Americas: breaking a historical legacy of slavery. PLoS Negl. Trop. Dis. 1:e71.
68. Lammie, P., T. Milner & R. Houston. 2007. Unfulfilled potential: using diethylcarbamazine-fortified salt to eliminate lymphatic filariasis. Bull. World Health Organ. 85:545 549.
69. Reddy, M., S.S. Gill, S.R. Kalkar, et al. 2007. Oral drug therapy for multiple neglected tropical diseases: a systematic review. JAMA 298:1911 1924.
70. Yamey, G. & P. Hotez. 2007. Neglected tropical diseases. BMJ 335:269 270.
71. Pichon, G. 2002. Limitation and facilitation in the vectors and other aspects of the dynamics of filarial transmission: the need for vector control against Anopheles-transmitted filariasis. Ann. Trop. Med. Parasitol. 96:S143 S152.